1-(2-Methoxyethyl)piperazine

Catalog No.: 
ACLBPE375
CAS No.: 
13484-40-7
Molecular Formula: 
C7H16N2O
Molecular Weight: 
144.22
1-(2-Methoxyethyl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g96%$148.00In stockInquiry
500g96%$725.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Methoxyethyl)piperazine
IUPAC Name1-(2-methoxyethyl)piperazine
MDL No.MFCD00191214
Molecular FormulaC7H16N2O
Molecular Weight144.22
SMILESCOCCN1CCNCC1
InChI KeyBMEMBBFDTYHTLH-UHFFFAOYSA-N
Synonym1-(2-methoxyethyl)piperizine | 1-N- Methoxyethyl piperazine | CS-W002493 | 1-2-methoxyethyl piperazin | Piperazine, 1-(2-methoxyethyl)- | N-(2-methoxyethyl)piperazine | N-(2-methoxyethyl)-piperazine | 1-(2-methoxyethyl) piperazine | Methyl 2-(1-Piperaziny
CAS No.13484-40-7
PubChem CID2734638

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACLBPE375 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACUGEK285 route compound structure diagram
    ACUGEK28534803-66-2In Stock
  6. Then
  7. ACLBPE375 route product structure diagram
    ACLBPE37513484-40-7In Stock
Inquiry

2. ACLBPE375 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLBPE375 route product structure diagram
    ACLBPE37513484-40-7In Stock
Inquiry

3. ACLBPE375 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLBPE375 route product structure diagram
    ACLBPE37513484-40-7In Stock
Inquiry

Comments (0)